BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28160423)

  • 1. Polymeric Delivery of siRNA against Integrin-β1 (CD29) to Reduce Attachment and Migration of Breast Cancer Cells.
    Meenakshi Sundaram DN; Kucharski C; Parmar MB; Kc RB; Uludağ H
    Macromol Biosci; 2017 Jun; 17(6):. PubMed ID: 28160423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI.
    Dastpeyman M; Motamed N; Azadmanesh K; Mostafavi E; Kia V; Jahanian-Najafabadi A; Shokrgozar MA
    Med Oncol; 2012 Dec; 29(4):2512-8. PubMed ID: 22101790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linoleic-acid-substituted polyethylenimine to silence heat shock protein 90B1 (HSP90B1) to inhibit migration of breast cancer cells.
    Meenakshi Sundaram DN; Kc RB; Uludağ H
    J Gene Med; 2022 Jun; 24(6):e3419. PubMed ID: 35373897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
    Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
    Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
    Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
    Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Sal-like 4 - integrin α6β1 network promotes cell migration for metastasis via activation of focal adhesion dynamics in basal-like breast cancer cells.
    Itou J; Tanaka S; Li W; Iida A; Sehara-Fujisawa A; Sato F; Toi M
    Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):76-88. PubMed ID: 27773610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase.
    McSherry EA; Brennan K; Hudson L; Hill AD; Hopkins AM
    Breast Cancer Res; 2011 Mar; 13(2):R31. PubMed ID: 21429211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer.
    Hamurcu Z; Kahraman N; Ashour A; Ozpolat B
    Breast Cancer Res Treat; 2017 Jun; 163(3):485-493. PubMed ID: 28361350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion and migration of extracellular matrix-stimulated breast cancer.
    Bartsch JE; Staren ED; Appert HE
    J Surg Res; 2003 Mar; 110(1):287-94. PubMed ID: 12697413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
    Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
    Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRL-3/PTP4A3 phosphatase regulates integrin β1 in adhesion structures during migration of human ocular melanoma cells.
    Foy M; Anézo O; Saule S; Planque N
    Exp Cell Res; 2017 Apr; 353(2):88-99. PubMed ID: 28284838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells.
    Parmar MB; Arteaga Ballesteros BE; Fu T; K C RB; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
    J Biomed Mater Res A; 2016 Dec; 104(12):3031-3044. PubMed ID: 27465922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
    McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
    Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrins synergise to induce expression of the MRTF-A-SRF target gene ISG15 for promoting cancer cell invasion.
    Hermann MR; Jakobson M; Colo GP; Rognoni E; Jakobson M; Kupatt C; Posern G; Fässler R
    J Cell Sci; 2016 Apr; 129(7):1391-403. PubMed ID: 26872785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of VAMP3 inhibits cell migration and integrin-mediated adhesion.
    Luftman K; Hasan N; Day P; Hardee D; Hu C
    Biochem Biophys Res Commun; 2009 Feb; 380(1):65-70. PubMed ID: 19159614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear SIPA1 activates integrin β1 promoter and promotes invasion of breast cancer cells.
    Zhang Y; Gong Y; Hu D; Zhu P; Wang N; Zhang Q; Wang M; Aldeewan A; Xia H; Qu X; Ring BZ; Minato N; Su L
    Oncogene; 2015 Mar; 34(11):1451-62. PubMed ID: 24704834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line.
    Aletaha M; Mansoori B; Mohammadi A; Fazeli M; Baradaran B
    Biomed Pharmacother; 2017 Apr; 88():34-42. PubMed ID: 28092843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
    Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
    Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effect of bone sialoprotein silencing on the adhesion ability of breast cancer cells to bone matrix].
    Wang L; Wang J; Yang D; Yang C; Xia B; Wang J; Xian J
    Sheng Wu Gong Cheng Xue Bao; 2011 Feb; 27(2):233-9. PubMed ID: 21650048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced radiosensitivity of head and neck squamous cell carcinoma cells by β1 integrin inhibition.
    Eke I; Dickreuter E; Cordes N
    Radiother Oncol; 2012 Aug; 104(2):235-42. PubMed ID: 22748391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.